Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 Healthcare Stocks Under $10 Ready To Pop

Investing in the healthcare sector can be tricky, especially if you’re looking for high returns and want to invest in clinical-stage companies, which represent an above-average risk. Many retail investors do not want to dispense a significant amount of money to take a shot at the sector and that is where we come in. We have compiled a list of five healthcare companies which have stock prices under $10 and have a significant potential to the upside. In fact, the validation of their future prospects comes from professional money managers themselves, and not just any professional money managers, but only the very elite among them, whom we exclusively track. These hedge funds have taken significant positions in these companies after rigorous research and we believe you should carefully consider adding these stocks to your own portfolio.

Tarchyshnik Andrei/

Tarchyshnik Andrei/

Let’s first take a step back and analyze how tracking hedge funds can help an everyday investor. Through our research we discovered that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith (and money) in large-cap stocks. In forward tests since August 2012 these top small-cap stocks beat the market by an impressive 60 percentage points, returning 118% (read the details here). Follow the smart money into only their best investment ideas all while avoiding their high fees.

In fifth place is the biopharmaceutical company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Even though the company’s stock price has slid by more than 36% so far this year, a total of 25 hedge funds among those that we track had an aggregate investment of $266.34 million in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) at the end of June. The aggregate stakes represent 25.6% of the company’s outstanding shares. Peter Kolchinsky‘s RA Capital Management is the largest stockholder of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) within our database and increased its stake by 22% during the second quarter to 9.95 million shares.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.